CFGS
BSX icon

Concourse Financial Group Securities’s Boston Scientific BSX Stock Holding History

Concourse Financial Group Securities’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,721
Closed -$674K – 269
2024
Q4 		$674K Sell
6,721
-319
-5% -$28.1K 0.04% 411
2024
Q3 		$590K Sell
7,040
-677
-9% -$53.4K 0.04% 422
2024
Q2 		$594K Sell
7,717
-124
-2% -$9.08K 0.04% 403
2024
Q1 		$537K Buy
7,841
+570
+8% +$36.6K 0.03% 429
2023
Q4 		$420K Sell
7,271
-102
-1% -$5.45K 0.03% 477
2023
Q3 		$389K Sell
7,373
-423
-5% -$22.2K 0.03% 460
2023
Q2 		$422K Buy
7,796
+2,857
+58% +$149K 0.03% 466
2023
Q1 		$247K Buy
4,939
+1,916
+63% +$90.3K 0.02% 589
2022
Q4 		$140K Sell
3,023
-261
-8% -$11.3K 0.01% 727
2022
Q3 		$127K Sell
3,284
-304
-8% -$12.2K 0.01% 654
2022
Q2 		$134K Sell
3,588
-514
-13% -$20.9K 0.01% 714
2022
Q1 		$182K Sell
4,102
-747
-15% -$32.4K 0.01% 658
2021
Q4 		$206K Buy
4,849
+113
+2% +$4.75K 0.01% 719
2021
Q3 		$205K Buy
4,736
+1,197
+34% +$53K 0.01% 711
2021
Q2 		$151K Buy
3,539
+35
+1% +$1.47K 0.01% 814
2021
Q1 		$135K Sell
3,504
-1,662
-32% -$62.9K 0.01% 812
2020
Q4 		$186K Sell
5,166
-9,919
-66% -$357K 0.01% 650
2020
Q3 		$576K Buy
15,085
+1,341
+10% +$51.7K 0.05% 308
2020
Q2 		$483K Buy
13,744
+1,646
+14% +$59.3K 0.05% 314
2020
Q1 		$395K Sell
12,098
-1,535
-11% -$60K 0.04% 294
2019
Q4 		$616K Buy
13,633
+8,785
+181% +$368K 0.06% 242
2019
Q3 		$197K Buy
4,848
+528
+12% +$22.4K 0.05% 297
2019
Q2 		$186K Buy
4,320
+999
+30% +$38.4K 0.02% 489
2019
Q1 		$127K Sell
3,321
-2,312
-41% -$88.3K 0.01% 606
2018
Q4 		$199K Buy
5,633
+4,792
+570% +$174K 0.02% 430
2018
Q3 		$32K Buy
+841
New +$29.4K 0.01% 691

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Concourse Financial Group Securities's BSX Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 6,721 shares — an estimated $674K sold.

Concourse Financial Group Securities first reported a position in BSX in Q3 2018 and held it in 26 quarters. The position peaked at $674K in Q4 2024. 1,643 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 6,721 Boston Scientific shares in Q1 2025, an estimated $674K.
  • Concourse Financial Group Securities first reported a position in Boston Scientific in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's Boston Scientific position peaked at $674K in Q4 2024.
  • 1,643 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.